Treatment of COVID-19 during the Acute Phase in Hospitalized Patients Decreases Post-Acute Sequelae of COVID-19

Background: The post-acute sequelae of SARS-CoV-2 (PASC) infection have caused a significant impact on our health system, but there is limited evidence of approved drugs focused on its prevention. Our objective was to identify risk factors that can determine the presence of PASC, with special attent...

Descripción completa

Detalles Bibliográficos
Autores principales: Badenes Bonet, Diana, Caguana Vélez, Oswaldo Antonio, Duran Jordà, Xavier, Comas Serrano, Merce, Posso Rivera, Margarita, Admetlló, Mireia, Herranz Blasco, Anna, Cuadrado Godia, Elisa, Marco Navarro, Ester, Martin Ezquerra, Gemma, Pineiro Aguin, Zenaida, Cumpli Gargallo, Maria Cinta, Gonzalez Garcia, Jose Gregorio, Balcells Vilarnau, Eva, Rodriguez Chiaradia, Diego, Castells, Xavier, Gea, Joaquim, Horcajada, Juan P., Villar-García, Judit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299438/
https://www.ncbi.nlm.nih.gov/pubmed/37373850
http://dx.doi.org/10.3390/jcm12124158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299438/
https://www.ncbi.nlm.nih.gov/pubmed/37373850
http://dx.doi.org/10.3390/jcm12124158

Ejemplares similares